Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Elon Musk Can’t Change the Fundamental Value of Twitter. Don’t Buy In.

By Dana Blankenhorn, InvestorPlace Contributor

Twitter is still a money-losing social network trying to scrounge cash from users. Musk's move doesn't change the true value of TWTR stock.

Qualcomm and the Great Tech Downgrade

By Dana Blankenhorn, InvestorPlace Contributor

Analysts fear smartphone demand is peaking, while Qualcomm insists it has vast new markets for communication chips.

Alibaba Stock: Witnessing the Fall of a Great Cloud Titan

By Dana Blankenhorn, InvestorPlace Contributor

Alibaba is still growing, but BABA stock remains depressed as China's tech crackdown has clobbered both American and Chinese investors.

Advanced Micro Devices: What’s Good Is Good

By Dana Blankenhorn, InvestorPlace Contributor

AMD bought Xilinx and Pensando to increase its share in the data center, a huge market that's growing over 20% per year.

Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks

By Dana Blankenhorn, InvestorPlace Contributor

Cash will be king in biotech picks like BLUE stock as governments slow approvals and reimbursements of new gene therapies.

Starbucks: Howard Schultz’ End Game

By Dana Blankenhorn, InvestorPlace Contributor

Legendary CEO Howard Schultz has gotten a rough reception since returning to the big chair but there's a great successor available.

You Can Buy the Bounce on PayPal But Be Cautious

By Dana Blankenhorn, InvestorPlace Contributor

Analysts were wrong to ignore PYPL Stocks' problems last year and investors lost money PayPal fell with international tensions, the rising cost of money, and an abortive effort to buy Pinterest. It's now cheap enough to buy.

Meta Platforms Is Too Cheap to Keep Selling

By Dana Blankenhorn, InvestorPlace Contributor

Meta CEO Mark Zuckerberg has proven detractors wrong before, and his company has prospered from it. Now his top-down vision faces its stiffest test. FB Stock has bounced off its lows but technology analysts continue to doubt the top-down future of its CEO.

Buying American Airlines Is Betting on an Earnings Beat

By Dana Blankenhorn, InvestorPlace Contributor

AAL stock may be an interesting speculation with the pandemic ending, but it's still not an investment.

Affirm Stock Is a Good Short-Term Buy

By Dana Blankenhorn, InvestorPlace Contributor

Buy Now, Pay Later was seen as a tech play when Affirm stock was rising last year. Now banks have matched the technology. AFRM stock has bounced off its lows, but it may never hit the heights of last year, when Buy Now Pay Later was the future of shopping.

Load More